Mesenchymal stem cells derived from bone marrow and leukapheresis show different putative subpopulations


https://doi.org/10.4081/scs.2011.e19
Vol. 1 No. 1 (2011)
Submitted: 28 August 2011
Accepted: 20 October 2011
Published: 21 October 2011
leukapheresis, mesenchymal stem cells, Oct4, CD44.
Abstract Views: 796
PDF: 547
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Hala Gabr Metwally Clinical Pathology Department, Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt.
  • Raafat Abd El-Fattah Clinical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Dina Ahmed Clinical Pathology Department, Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt.
  • Marwa Farhan Clinical Pathology Department, Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt.
  • Somaia Mohammed Mousa
    smamousa@gmail.com
    Clinical Pathology Department, Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt.
Mesenchymal stem cells (MSCs), with their high proliferative and differentiation potential, in addition to their plasticity, are promising candidates for cell therapeutic applications. Bone marrow (BM) harvest is still the main source of MSCs in spite of being traumatic and painful. Clinical indications for peripheral blood-derived MSCs are rapidly increasing. This study was done to compare the biological properties of MSCs derived from BM and leukapheresis product regarding viability, fold expansion, cell cycle status and putative subpopulations. MSCs were isolated and cultured from BM and leukapheresis samples after stem cell mobilization. MSCs were characterized by morphology and immunophenotyping. Their viability, fold expansion and cell cycle status were compared. Estimation of putative cells among the mesenchymal population was done by dual expression of CD44 and Oct4. Leukapheresis derived MSCs were found to be comparable to BM-MSCs regarding their viability, fold expansion and cell cycle status, however they differ in their putative subpopulations. BM samples had significantly higher percentage of putative population than leukapheresis samples (18.38± 3.21% vs 5.43± 1.26%, P=0.009). These results indicated the possible isolation and expansion of MSCs from leukapheresis samples. The lower putative subpopulations among leukapheresis derived MSCs may be due to lack of BM microenvironment related factors needed to maintain pluripotency or due to the current methods of cell mobilization that have been optimized for hematopoietic stem cells rather than MSCs.

Supporting Agencies


Metwally, H. G., Abd El-Fattah, R., Ahmed, D., Farhan, M., & Mousa, S. M. (2011). Mesenchymal stem cells derived from bone marrow and leukapheresis show different putative subpopulations. Stem Cell Studies, 1(1), e19. https://doi.org/10.4081/scs.2011.e19

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC